Prevalência de tripanossomíase americana, sífilis, toxoplasmose, rubéola, hepatite B, hepatite C e da infecção pelo vírus da imunodeficiência humana, avaliada por intermédio de testes sorológicos, em gestantes atendidas no período de 1996 a 1998 no Hospital Universitário Regional Norte do Paraná (Universidade Estadual de Londrina, Paraná, Brasil)

Abstract

In order to evaluate the seroprevalence of the american trypanosomiasis, syphilis, toxoplasmosis, rubella, hepatitis B infection, hepatitis C infection and human immunodeficiency virus infection among pregnant women attended at the Hospital Universitário Regional Norte do Paraná, Londrina State University, Paraná, a retrospective study of the serologic results performed in the prenatal routine during the period of June 1996 to June 1998 was carried out. The rates of seropositivity were as follows: american trypanosomiasis = 0.9%, syphilis = 1.6%, toxoplasmosis = 67% (IgG) and 1.8% (IgM), rubella = 89% (IgG) and 1.2% (IgM), hepatitis B surface antigen = 0.8%, hepatitis C virus = 0.8% and human immunodeficiency virus infection = 0.6%. An association between the increase in the seroprevalence of Chagas' disease and patient age was detected (p=0.006). The results underscore the importance of the serological tests in perinatal care, to prevent both the congenital and perinatally transmitted forms of theses infectious diseases.

Prevalência do HBsAg em gestantes de Passo Fundo, RS: estudo comparativo entre os sistemas de saúde público e privado

“…É importante ressaltar o grande número de pacientes incluído (mais de 3.500) e a adequada representatividade dos centros de saúde pesquisados, abrangendo serviços públicos e privados de uma cidade de médio porte, com elevada circulação de pacientes. Em concordância com esse achado, estudos realizados em outras regiões populosas do Brasil têm descrito prevalência de HBsAg entre 0,4 e 0,8% (1,4) . .…”

Seropositivity rates for toxoplasmosis, rubella, syphilis, cytomegalovirus, hepatitis and HIV among pregnant women receiving care at a public health service, São Paulo state, Brazil

“…In the north of Paraná State, rates of 67.0% (IgG-toxo), 1.8% (IgM-toxo), 89.0% (IgG anti-rubella), 1.2% (IgM antirubella), 1.6% (syphilis), 0.8% (hepatitis B), 0.8% (hepatitis C) and 0.6% (HIV) were reported in one study. 3 In the state of Mato Grosso do Sul, the percentages were 0.4% for IgM-toxo, 0.03% for IgM anti-rubella, 0.8% for syphilis, 0.3% for hepatitis B, 0.1% for hepatitis C and 0.2% for HIV. 4 Recent studies with pregnant women in the northwest region of São Paulo State reported IgG-toxo antibodies in 64.1% 5 and 1.03% of HIV seropositivity, 6 but did not detail the results of other TORSCH infections.…”

“…The risks are associated with their higher rates in less well educated populations. 3 Knowledge of the prevalence and incidence of these infectious-parasitic diseases in pregnant women is of great importance in the planning of maternal-fetal health programs strategies, screening and treatment of these diseases. 4 Serological tests to diagnose infections of the TORSCH (Toxoplasmosis, Rubella, Syphilis, Cytomegalovirus, Hepatitis B and C, and HIV) are mandatory, as they pose a potential life threatening risk for the pregnant woman and their fetus, in addition to the newborn baby after delivery.…”

“…4 Serological tests to diagnose infections of the TORSCH (Toxoplasmosis, Rubella, Syphilis, Cytomegalovirus, Hepatitis B and C, and HIV) are mandatory, as they pose a potential life threatening risk for the pregnant woman and their fetus, in addition to the newborn baby after delivery. 3,4 With the exception of infections by cytomegalovirus, the other diseases are routinely investigated in all pregnant women attending the high-risk pregnancy and fetal medicine unit of Hospital de Base (FUNFARME) in São José do Rio Preto, a reference center for the northwest region of São Paulo State.…”

Serological, epidemiological and molecular aspects of hepatitis C virus infection in a population from Londrina, PR, Brazil, 2001-2002

“…In Londrina, Paraná, data are also very scarce. PONTELLO et al (1993) detected 1.2% positivity of anti-HCV antibodies in blood donors 23 , and REICHE et al (2000), studying 1,006 pregnant women assisted at a University Hospital during the period from 1996-1998, reported 0.8% positivity determined by enzyme immunoassay (ELISA), with no confirmation of antibody specificity or determination of the presence of HCV-RNA in seropositive cases 24 .…”